Silence Therapeutics plc Postemployment Benefits, Period Expense
Silence Therapeutics plc (SLNCF) reported Postemployment Benefits, Period Expense of $748.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PostemploymentBenefitsPeriodExpense · last filed 2026-03-05
- Silence Therapeutics plc postemployment benefits, period expense for fiscal 2025 was $748.00K, a 12.31% increase from fiscal 2024.
- Silence Therapeutics plc postemployment benefits, period expense for fiscal 2024 was $666.00K, a 9.36% increase from fiscal 2023.
- Silence Therapeutics plc postemployment benefits, period expense for fiscal 2023 was $609.00K, a 14.69% increase from fiscal 2022.
- Silence Therapeutics plc postemployment benefits, period expense for fiscal 2022 was $531.00K.
| Period end | Postemployment Benefits, Period Expense 12 month |
|---|---|
| 2025-12-31 | $748.00K 10-K · filed 2026-03-05 |
| 2024-12-31 | $666.00K 10-K · filed 2026-03-05 |
| 2023-12-31 | $609.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | $531.00K 10-K · filed 2025-02-27 |